Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results, page-38

What has Kim actually delivered in those 16 months, imo so far nothing.
Recruitment for continued phase 2b trial in NZ was anticipated to commence last December and we have not been told what is happening
APMA Approvals to export MPL tablets into USA for phase 3 trials was due first week in January
Negotiating with US sites and ethics was to be completed by end of January
Delivery GMP MPL on site US was due first week of February
Start of US sites was front 7 February
Not one word about any of the above since, now I am not sure if new mpl and new tablets are required for phrase 3 trials.
Roger was asked this question either August or September but did not answer the question as it appeared he had no clue.

I make the assumption some of the above if not all would fall on Kim's shoulder and considering nothing has been reported Kim has not delivered to timelines, hasn't push to announce delays and why would he as its common for PAA not to report delays until well after the expected date of the delayed event.